Concepedia

Joshua Odingo

JO

21

Publications

864

Citations

18

H-Index

1993

Active since

Affiliations

Infectious Disease Research Institute(Current)

Eli Lilly (United States)

Jubilant Life Sciences (India)

Columbia University

University of Cape Town

Joshua Odingo is an author at Infectious Disease Research Institute specializing in medicine, drug resistance, and pharmacology.

Top concepts

Publications per year

1993–2021

21

Publications

21

Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target

Juliane Ollinger, Theresa O’Malley, Edward A. Kesicki et al. · Journal of Bacteriology · 2011 · 130 citations · Full text

Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists

Shelley Allen, Bradley J. Newhouse, Aaron S. Anderson et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 66 citations · Full text

, , +3

Improved Phenoxyalkylbenzimidazoles with Activity against <i>Mycobacterium tuberculosis</i> Appear to Target QcrB

N. Susantha Chandrasekera, Bryan J. Berube, Gauri Shetye et al. · ACS Infectious Diseases · 2017 · 66 citations · Full text

Circular dichroism exciton chirality method. New red-shifted chromophores for hydroxyl groups

Guolin Cai, Niva Bozhkova, Joshua Odingo et al. · Journal of the American Chemical Society · 1993 · 65 citations

, , +19

Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents

Edward A. Kesicki, Mai A. Bailey, Yulia Ovechkina et al. · PLoS ONE · 2016 · 57 citations · Full text

, , +17

Rows per page

1–5 of 21